Internal Medicine, Cardiovascular Disease · Boston, MA
NPI
1124024013
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
133 Brookline Ave, Harvard Vanguard Medical Associates
Boston, MA, 02215
Phone (617) 421-6050
Groups this clinician bills Medicare through
Medicare paid, 2024
$319K
8,385 services
Medicare patients, 2024
2,122
Average age 76
Drug cost, 2024
$2.1M
8,203 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marshall S Katz was code 36415 (venipuncture blood collection), 829 times for 383 patients. In total Marshall S Katz billed 8,385 services in 109 codes, and Medicare paid $319K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 829 | 383 | $8.65 | $7,171 |
| 99214 Office E&M - Established | Office | 813 | 581 | $94.38 | $77K |
| 93000 Electrocardiogram | Office | 776 | 748 | $11.46 | $8,896 |
| 82565 Clinical Chemistry | Office | 580 | 259 | $5.02 | $2,912 |
| 80051 Clinical Chemistry | Office | 567 | 236 | $6.87 | $3,895 |
| 93294 External Electrocardiographic Monitoring | Office | 528 | 294 | $20.42 | $11K |
| 93296 External Electrocardiographic Monitoring | Office | 527 | 292 | $16.32 | $8,598 |
| 83880 Clinical Chemistry | Office | 464 | 162 | $38.47 | $18K |
| 80061 Clinical Chemistry | Office | 325 | 240 | $13.12 | $4,264 |
| 93306 Echocardiography (TTE/TEE) | Office | 301 | 297 | $158.67 | $48K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 297 | 287 | $13.49 | $4,008 |
| 93298 External Electrocardiographic Monitoring | Office | 221 | 60 | $53.14 | $12K |
| 84460 Clinical Chemistry | Office | 211 | 157 | $5.19 | $1,095 |
| 99215 Office E&M - Established | Office | 185 | 157 | $148.78 | $28K |
| 93248 Electrocardiogram | Office | 161 | 156 | $20.34 | $3,275 |
By year: 2022 $262K for 6,605 services; 2023 $283K for 6,961 services; 2024 $319K for 8,385 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 829 | 383 | $8.65 | $7,171 |
| 82565 Clinical Chemistry | 580 | 259 | $5.02 | $2,912 |
| 80051 Clinical Chemistry | 567 | 236 | $6.87 | $3,895 |
| 83880 Clinical Chemistry | 464 | 162 | $38.47 | $18K |
| 80061 Clinical Chemistry | 325 | 240 | $13.12 | $4,264 |
| 84460 Clinical Chemistry | 211 | 157 | $5.19 | $1,095 |
| 85014 Blood Count | 100 | 89 | $2.32 | $232 |
| 85018 Blood Count | 99 | 88 | $2.32 | $230 |
| 84520 Clinical Chemistry | 53 | 33 | $3.87 | $205 |
| 85025 Blood Count | 53 | 51 | $7.61 | $403 |
Medicare prescription drug claims, 2024
In 2024, the drug Marshall S Katz prescribed most often to Medicare patients was Atorvastatin Calcium, with 945 prescriptions and refills. In total Marshall S Katz wrote 8,203 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 945 | 2,751 | 288 | $16K |
| Metoprolol Succinate Generic | 855 | 2,467 | 260 | $17K |
| Eliquis Apixaban | 827 | 1,718 | 188 | $965K |
| Amlodipine Besylate Generic | 439 | 1,258 | 134 | $3,624 |
| Furosemide Generic | 429 | 1,047 | 126 | $2,882 |
| Rosuvastatin Calcium Generic | 363 | 1,041 | 112 | $11K |
| Losartan Potassium Generic | 349 | 987 | 100 | $4,526 |
| Lisinopril Generic | 347 | 1,015 | 101 | $3,107 |
| Ezetimibe Generic | 309 | 861 | 97 | $13K |
| Jardiance Empagliflozin | 274 | 626 | 69 | $355K |
| Xarelto Rivaroxaban | 206 | 446 | 49 | $239K |
| Spironolactone Generic | 182 | 504 | 59 | $1,624 |
| Atenolol Generic | 144 | 382 | 42 | $1,559 |
| Torsemide Generic | 143 | 369 | 43 | $6,756 |
| Repatha Sureclick Evolocumab | 134 | 211 | 26 | $117K |
Brand drugs: 1,806 claims; generic drugs: 6,397 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Marshall S Katz were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.